Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

KLINIK FOR TANDSUNDHED, HOLISTISKE TANDLÆGER ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Bankruptcy risk for industry   0.5% 0.5% 0.5% 0.5% 0.5% 0.5% 0.5% 0.5%   Bankruptcy risk   9.8% 8.3% 5.0% 2.8% 4.1% 2.9% 19.5% 19.2%   Credit score (0-100)   26 29 42 59 48 58 6 7   Credit rating   BB BB BBB BBB BBB BBB B B   Credit limit (kDKK)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   3,256 2,896 3,461 2,966 2,919 2,283 0.0 0.0   EBITDA   1,245 1,101 1,408 860 1,000 718 0.0 0.0   EBIT   1,194 1,037 1,347 789 966 692 0.0 0.0   Pre-tax profit (PTP)   1,192.9 1,030.5 1,341.6 806.9 1,009.0 728.0 0.0 0.0   Net earnings   996.8 737.2 1,046.4 629.0 787.3 567.8 0.0 0.0   Pre-tax profit without non-rec. items   1,193 1,031 1,342 807 1,009 728 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Tangible assets total   184 120 112 116 81.9 56.3 0.0 0.0   Shareholders equity total   -297 441 1,387 1,016 1,203 971 46.2 46.2   Interest-bearing liabilities   753 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   838 828 2,093 1,463 1,745 1,437 46.2 46.2   Net Debt   599 -207 -125 -188 -502 -338 -46.2 -46.2     See the entire balance sheet 1000.0 Volume  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   3,256 2,896 3,461 2,966 2,919 2,283 0.0 0.0   Gross profit growth   -7.6% -11.0% 19.5% -14.3% -1.6% -21.8% -100.0% 0.0%   Employees   5 0 4 4 4 4 0 0   Employee growth %   -16.7% -100.0% 0.0% 0.0% 0.0% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   838 828 2,093 1,463 1,745 1,437 46 46   Balance sheet change%   -60.5% -1.1% 152.7% -30.1% 19.2% -17.6% -96.8% 0.0%   Added value   1,245.3 1,101.3 1,408.1 860.2 1,037.8 717.5 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -103 -129 -69 -68 -68 -51 -56 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   1.0 2.0 3.0 4.0 5.0 5.0 0.0 0.0   1000.0 Profitability  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   36.7% 35.8% 38.9% 26.6% 33.1% 30.3% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   52.5% 105.7% 92.2% 45.8% 63.0% 46.0% 0.0% 0.0%   ROI %   317.2% 173.8% 147.4% 67.8% 91.1% 67.4% 0.0% 0.0%   ROE %   67.4% 115.3% 114.5% 52.4% 70.9% 52.2% 0.0% 0.0%   1000.0 Solidity  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Equity ratio %   -26.2% 53.2% 66.3% 69.4% 69.0% 67.6% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   48.1% -18.8% -8.9% -21.8% -50.2% -47.1% 0.0% 0.0%   Gearing %   -253.7% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   0.2% 1.7% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Liquidity  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Quick Ratio   0.5 1.6 2.7 2.8 2.9 2.8 0.0 0.0   Current Ratio   0.5 1.6 2.7 2.8 2.9 2.8 0.0 0.0   Cash and cash equivalent   153.9 206.6 125.0 187.9 501.8 337.8 0.0 0.0   1000.0 Capital use efficiency  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   -557.8 242.5 1,196.0 811.9 1,033.1 826.1 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   249 0 352 215 259 179 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   249 0 352 215 250 179 0 0   EBIT / employee   239 0 337 197 242 173 0 0   Net earnings / employee   199 0 262 157 197 142 0 0